Cytokine-mobilized peripheral blood progenitor cells for allogeneic reconstitution of miniature swine

Christine Colby, Qing Chang, Yasushi Fuchimoto, Vincent Ferrara, Michael Murphy, Robert Sackstein, Thomas R. Spitzer, Mary E. White-Scharf, David H. Sachs

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

Background. Because of the relative ease of acquisition, increased yield, and improved engraftment characteristics, mobilized peripheral blood progenitor (stem) cells (PBSCs) have recently become the preferred source for hematopoietic stem cell transplantation. In our laboratory, procurement of a megadose of PBSCs is necessary for on-going studies evaluating non- myelosuppressive transplant regimens for the induction of mixed chimerism and allograft tolerance. To exploit hematopoietic growth factor synergy, we have sought to combine growth factors with proven utility to improve PBSC mobilization and maximize our PBSC procurement through an automated collection procedure. Methods. Mobilization characteristics of PBSCs were determined in 2-5-month-old miniature swine. Animals received either swine recombinant stem cell factor (pSCF, 100 μg/kg) and swine recombinant interleukin 3 (pIL-3, 100 μg/kg), administered intramuscularly for 8 days, or pSCF, pIL-3, and human recombinant granulocyte-colony stimulating factor (hG-CSF), at 10 μg/kg. Leukapheresis was performed beginning on day 5 of cytokine treatment and continued daily for 3 days. Results. Collection of PBSCs from cytokine-mobilized animals via an automated leukapheresis procedure demonstrated a 10-fold increase in the number of total nucleated cells (TNC) (20-30x1010 TNC) compared to bone marrow harvesting (2-3x1010 total TNC). A more rapid rise in white blood cells (WBCs) was seen after administration of all three cytokines compared to pSCF and pIL-3 alone. An increase in colony-forming unit granulocyte-macrophage frequency measured daily from peripheral blood during cytokine treatment, was seen with the addition of hG-CSF to pSCF/pIL-3 correlating well with the rise in WBCs. Similarly, the addition of hG-CSF demonstrated a notable increase in the median progenitor cell yield from the 3-day leukapheresis procedure. Cytokine-mobilized PBSCs were capable of hematopoietic reconstitution. PBSCs mobilized with pSCF/pIL-3 were infused into an SLA-matched recipient conditioned with cyclophosphamide (50 mg/kg) and total body irradiation 1150 cGy. Neutrophil and platelet engraftment occurred on days 5 and 7, respectively, with minimal evidence of graft-versus-host disease. Complete donor chimerism has been demonstrated 331 days after transplant. Conclusions. Our preliminary results show that in this well-defined miniature swine model, recombinant swine cytokine combinations (pSCF, pIL-3 with or without hG-CSF) successfully mobilize a high yield of progenitor cells for allogeneic transplantation. Furthermore, these cytokine-mobilized PBSCs demonstrate the potential to reconstitute hematopoiesis and provide long-term engraftment in miniature swine.

Original languageEnglish
Pages (from-to)135-140
Number of pages6
JournalTransplantation
Volume69
Issue number1
Publication statusPublished - 2000 Jan 15
Externally publishedYes

Fingerprint

Miniature Swine
Blood Cells
Stem Cells
Cytokines
Granulocyte Colony-Stimulating Factor
Leukapheresis
Chimerism
Swine
Intercellular Signaling Peptides and Proteins
Leukocytes
Hematopoietic Stem Cell Mobilization
Transplantation Tolerance
Transplants
Peripheral Blood Stem Cells
Granulocyte-Macrophage Progenitor Cells
Stem Cell Factor
Whole-Body Irradiation
Interleukin-3
Hematopoietic Stem Cell Transplantation
Cell Transplantation

ASJC Scopus subject areas

  • Transplantation
  • Immunology

Cite this

Colby, C., Chang, Q., Fuchimoto, Y., Ferrara, V., Murphy, M., Sackstein, R., ... Sachs, D. H. (2000). Cytokine-mobilized peripheral blood progenitor cells for allogeneic reconstitution of miniature swine. Transplantation, 69(1), 135-140.

Cytokine-mobilized peripheral blood progenitor cells for allogeneic reconstitution of miniature swine. / Colby, Christine; Chang, Qing; Fuchimoto, Yasushi; Ferrara, Vincent; Murphy, Michael; Sackstein, Robert; Spitzer, Thomas R.; White-Scharf, Mary E.; Sachs, David H.

In: Transplantation, Vol. 69, No. 1, 15.01.2000, p. 135-140.

Research output: Contribution to journalArticle

Colby, C, Chang, Q, Fuchimoto, Y, Ferrara, V, Murphy, M, Sackstein, R, Spitzer, TR, White-Scharf, ME & Sachs, DH 2000, 'Cytokine-mobilized peripheral blood progenitor cells for allogeneic reconstitution of miniature swine', Transplantation, vol. 69, no. 1, pp. 135-140.
Colby C, Chang Q, Fuchimoto Y, Ferrara V, Murphy M, Sackstein R et al. Cytokine-mobilized peripheral blood progenitor cells for allogeneic reconstitution of miniature swine. Transplantation. 2000 Jan 15;69(1):135-140.
Colby, Christine ; Chang, Qing ; Fuchimoto, Yasushi ; Ferrara, Vincent ; Murphy, Michael ; Sackstein, Robert ; Spitzer, Thomas R. ; White-Scharf, Mary E. ; Sachs, David H. / Cytokine-mobilized peripheral blood progenitor cells for allogeneic reconstitution of miniature swine. In: Transplantation. 2000 ; Vol. 69, No. 1. pp. 135-140.
@article{ab2a46837b9f4ffb85270531d0ca9313,
title = "Cytokine-mobilized peripheral blood progenitor cells for allogeneic reconstitution of miniature swine",
abstract = "Background. Because of the relative ease of acquisition, increased yield, and improved engraftment characteristics, mobilized peripheral blood progenitor (stem) cells (PBSCs) have recently become the preferred source for hematopoietic stem cell transplantation. In our laboratory, procurement of a megadose of PBSCs is necessary for on-going studies evaluating non- myelosuppressive transplant regimens for the induction of mixed chimerism and allograft tolerance. To exploit hematopoietic growth factor synergy, we have sought to combine growth factors with proven utility to improve PBSC mobilization and maximize our PBSC procurement through an automated collection procedure. Methods. Mobilization characteristics of PBSCs were determined in 2-5-month-old miniature swine. Animals received either swine recombinant stem cell factor (pSCF, 100 μg/kg) and swine recombinant interleukin 3 (pIL-3, 100 μg/kg), administered intramuscularly for 8 days, or pSCF, pIL-3, and human recombinant granulocyte-colony stimulating factor (hG-CSF), at 10 μg/kg. Leukapheresis was performed beginning on day 5 of cytokine treatment and continued daily for 3 days. Results. Collection of PBSCs from cytokine-mobilized animals via an automated leukapheresis procedure demonstrated a 10-fold increase in the number of total nucleated cells (TNC) (20-30x1010 TNC) compared to bone marrow harvesting (2-3x1010 total TNC). A more rapid rise in white blood cells (WBCs) was seen after administration of all three cytokines compared to pSCF and pIL-3 alone. An increase in colony-forming unit granulocyte-macrophage frequency measured daily from peripheral blood during cytokine treatment, was seen with the addition of hG-CSF to pSCF/pIL-3 correlating well with the rise in WBCs. Similarly, the addition of hG-CSF demonstrated a notable increase in the median progenitor cell yield from the 3-day leukapheresis procedure. Cytokine-mobilized PBSCs were capable of hematopoietic reconstitution. PBSCs mobilized with pSCF/pIL-3 were infused into an SLA-matched recipient conditioned with cyclophosphamide (50 mg/kg) and total body irradiation 1150 cGy. Neutrophil and platelet engraftment occurred on days 5 and 7, respectively, with minimal evidence of graft-versus-host disease. Complete donor chimerism has been demonstrated 331 days after transplant. Conclusions. Our preliminary results show that in this well-defined miniature swine model, recombinant swine cytokine combinations (pSCF, pIL-3 with or without hG-CSF) successfully mobilize a high yield of progenitor cells for allogeneic transplantation. Furthermore, these cytokine-mobilized PBSCs demonstrate the potential to reconstitute hematopoiesis and provide long-term engraftment in miniature swine.",
author = "Christine Colby and Qing Chang and Yasushi Fuchimoto and Vincent Ferrara and Michael Murphy and Robert Sackstein and Spitzer, {Thomas R.} and White-Scharf, {Mary E.} and Sachs, {David H.}",
year = "2000",
month = "1",
day = "15",
language = "English",
volume = "69",
pages = "135--140",
journal = "Transplantation",
issn = "0041-1337",
publisher = "Lippincott Williams and Wilkins",
number = "1",

}

TY - JOUR

T1 - Cytokine-mobilized peripheral blood progenitor cells for allogeneic reconstitution of miniature swine

AU - Colby, Christine

AU - Chang, Qing

AU - Fuchimoto, Yasushi

AU - Ferrara, Vincent

AU - Murphy, Michael

AU - Sackstein, Robert

AU - Spitzer, Thomas R.

AU - White-Scharf, Mary E.

AU - Sachs, David H.

PY - 2000/1/15

Y1 - 2000/1/15

N2 - Background. Because of the relative ease of acquisition, increased yield, and improved engraftment characteristics, mobilized peripheral blood progenitor (stem) cells (PBSCs) have recently become the preferred source for hematopoietic stem cell transplantation. In our laboratory, procurement of a megadose of PBSCs is necessary for on-going studies evaluating non- myelosuppressive transplant regimens for the induction of mixed chimerism and allograft tolerance. To exploit hematopoietic growth factor synergy, we have sought to combine growth factors with proven utility to improve PBSC mobilization and maximize our PBSC procurement through an automated collection procedure. Methods. Mobilization characteristics of PBSCs were determined in 2-5-month-old miniature swine. Animals received either swine recombinant stem cell factor (pSCF, 100 μg/kg) and swine recombinant interleukin 3 (pIL-3, 100 μg/kg), administered intramuscularly for 8 days, or pSCF, pIL-3, and human recombinant granulocyte-colony stimulating factor (hG-CSF), at 10 μg/kg. Leukapheresis was performed beginning on day 5 of cytokine treatment and continued daily for 3 days. Results. Collection of PBSCs from cytokine-mobilized animals via an automated leukapheresis procedure demonstrated a 10-fold increase in the number of total nucleated cells (TNC) (20-30x1010 TNC) compared to bone marrow harvesting (2-3x1010 total TNC). A more rapid rise in white blood cells (WBCs) was seen after administration of all three cytokines compared to pSCF and pIL-3 alone. An increase in colony-forming unit granulocyte-macrophage frequency measured daily from peripheral blood during cytokine treatment, was seen with the addition of hG-CSF to pSCF/pIL-3 correlating well with the rise in WBCs. Similarly, the addition of hG-CSF demonstrated a notable increase in the median progenitor cell yield from the 3-day leukapheresis procedure. Cytokine-mobilized PBSCs were capable of hematopoietic reconstitution. PBSCs mobilized with pSCF/pIL-3 were infused into an SLA-matched recipient conditioned with cyclophosphamide (50 mg/kg) and total body irradiation 1150 cGy. Neutrophil and platelet engraftment occurred on days 5 and 7, respectively, with minimal evidence of graft-versus-host disease. Complete donor chimerism has been demonstrated 331 days after transplant. Conclusions. Our preliminary results show that in this well-defined miniature swine model, recombinant swine cytokine combinations (pSCF, pIL-3 with or without hG-CSF) successfully mobilize a high yield of progenitor cells for allogeneic transplantation. Furthermore, these cytokine-mobilized PBSCs demonstrate the potential to reconstitute hematopoiesis and provide long-term engraftment in miniature swine.

AB - Background. Because of the relative ease of acquisition, increased yield, and improved engraftment characteristics, mobilized peripheral blood progenitor (stem) cells (PBSCs) have recently become the preferred source for hematopoietic stem cell transplantation. In our laboratory, procurement of a megadose of PBSCs is necessary for on-going studies evaluating non- myelosuppressive transplant regimens for the induction of mixed chimerism and allograft tolerance. To exploit hematopoietic growth factor synergy, we have sought to combine growth factors with proven utility to improve PBSC mobilization and maximize our PBSC procurement through an automated collection procedure. Methods. Mobilization characteristics of PBSCs were determined in 2-5-month-old miniature swine. Animals received either swine recombinant stem cell factor (pSCF, 100 μg/kg) and swine recombinant interleukin 3 (pIL-3, 100 μg/kg), administered intramuscularly for 8 days, or pSCF, pIL-3, and human recombinant granulocyte-colony stimulating factor (hG-CSF), at 10 μg/kg. Leukapheresis was performed beginning on day 5 of cytokine treatment and continued daily for 3 days. Results. Collection of PBSCs from cytokine-mobilized animals via an automated leukapheresis procedure demonstrated a 10-fold increase in the number of total nucleated cells (TNC) (20-30x1010 TNC) compared to bone marrow harvesting (2-3x1010 total TNC). A more rapid rise in white blood cells (WBCs) was seen after administration of all three cytokines compared to pSCF and pIL-3 alone. An increase in colony-forming unit granulocyte-macrophage frequency measured daily from peripheral blood during cytokine treatment, was seen with the addition of hG-CSF to pSCF/pIL-3 correlating well with the rise in WBCs. Similarly, the addition of hG-CSF demonstrated a notable increase in the median progenitor cell yield from the 3-day leukapheresis procedure. Cytokine-mobilized PBSCs were capable of hematopoietic reconstitution. PBSCs mobilized with pSCF/pIL-3 were infused into an SLA-matched recipient conditioned with cyclophosphamide (50 mg/kg) and total body irradiation 1150 cGy. Neutrophil and platelet engraftment occurred on days 5 and 7, respectively, with minimal evidence of graft-versus-host disease. Complete donor chimerism has been demonstrated 331 days after transplant. Conclusions. Our preliminary results show that in this well-defined miniature swine model, recombinant swine cytokine combinations (pSCF, pIL-3 with or without hG-CSF) successfully mobilize a high yield of progenitor cells for allogeneic transplantation. Furthermore, these cytokine-mobilized PBSCs demonstrate the potential to reconstitute hematopoiesis and provide long-term engraftment in miniature swine.

UR - http://www.scopus.com/inward/record.url?scp=0034650380&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034650380&partnerID=8YFLogxK

M3 - Article

C2 - 10653392

AN - SCOPUS:0034650380

VL - 69

SP - 135

EP - 140

JO - Transplantation

JF - Transplantation

SN - 0041-1337

IS - 1

ER -